Top compounds associated with response to POM121L12


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib GDSC1000 pan-cancer AAC -0.064 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.2
mRNA importazole CTRPv2 pan-cancer AAC -0.048 0.2
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.043 0.2
mRNA BRD-K51490254 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA Erlotinib gCSI pan-cancer AAC -0.069 0.2
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.041 0.2
mRNA LY317615 GDSC1000 pan-cancer AAC -0.042 0.2
mRNA tamatinib CTRPv2 pan-cancer AAC -0.046 0.2
mRNA AICAR GDSC1000 pan-cancer AAC -0.04 0.2
Download CSV